The increasing frequency of pelvic floor diseases worldwide, as well as rising healthcare spending, are driving the growth of the pelvic floor diagnostics market. The advancement of technologically superior diagnostic systems, along with government backing, has resulted in an increase in demand for dependable and comprehensive diagnostic systems.
Manufacturers have begun to invest in medical devices as healthcare spending has increased and financing has increased due to favorable reimbursement. As a result, there has been a rise in the use of pelvic floor diagnostics, as well as the expansion of other related markets, such as the treatment of pelvic floor prolapse and other dysfunctions.
Leading companies in the worldwide pelvic floor diagnostics market are investing in R&D to provide novel and effective pelvic floor diagnostic devices. In addition, attractive growth tactics will continue to include collaborations, mergers, and acquisitions for manufacturing facility development. Consider the following example
HOYA Corporation inked a five-year deal with Hitachi in March 2021 for technology improvements and the delivery of diagnostic ultrasound equipment and sensors. Further, Analytica Ltd. formed a joint venture with Shijiazhuang Biosphere Pty Ltd. and Hebei Nacol Bio-Technology Co. Ltd. to manufacture and distribute their Pericoach urinary incontinence device in April 2021.
Europe is likely to grow at a significant level in the forecast time frame. UK is projected to lead in the European market with a CAGR of 5.7% during the forecast timeframe. Due to the increasing elder population in the region and government support to raise funds. Further, Latin America is likely to support the growth of the market. Brazil is dominating in the region with 42.3% of market share in 2020 owing to increasing pelvic floor disorders in the region.
Despite a huge decline in the sales of products during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up a quick pace for registering a CAGR of almost more than 4.3%, during the tenure of 2021 – 2027.
The report published by Maximize encompasses the market dynamics, which could affect the market growth of Pelvic Floor Diagnostic Testing in the region, the Value – Chain Analysis, and the PORTER’s analysis for the Pelvic Floor Diagnostic Testing market at a global level. The study is associated based on major segments and further into sub-segments, by Product Urodynamics Systems, Uroflowmetry Devices, Anal Manometry Systems, Cystoscopes, Ultrasound Systems, Cart/Trolley Based, Portable Bladder Ultrasound Systems, EMG) and End-User (Hospital, and Clinic) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2020, considering 2020 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players- Laborie, Inc., Cooper Surgical Inc., Medtronic Plc., SRS Medical, Stryker’s, MEDSPIRA, MEDKONSULT medical technology s.r.o., EndoMed Systems, Richard Wolf, Schölly Fiberoptic, Zhuhai Seesheen Medical Technology, KARL STORZ, Cadwell, The Prometheus Group, Neurosoft, Noraxon USA.
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on the “Global Pelvic Floor Diagnostic Testing Market.”
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
Omkar Heights,
ManikBaug, Vadgaon Bk,
Sinhagad Road, Pune – 411051,
Maharashtra, India.
+91 9607195908